惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
The Cloudflare Blog
有赞技术团队
有赞技术团队
H
Help Net Security
V
Visual Studio Blog
F
Fortinet All Blogs
Apple Machine Learning Research
Apple Machine Learning Research
博客园 - 司徒正美
G
Google Developers Blog
Google DeepMind News
Google DeepMind News
腾讯CDC
H
Hackread – Cybersecurity News, Data Breaches, AI and More
Stack Overflow Blog
Stack Overflow Blog
I
InfoQ
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
L
LangChain Blog
N
Netflix TechBlog - Medium
罗磊的独立博客
The GitHub Blog
The GitHub Blog
云风的 BLOG
云风的 BLOG
Hugging Face - Blog
Hugging Face - Blog
A
About on SuperTechFans
aimingoo的专栏
aimingoo的专栏
Recent Announcements
Recent Announcements

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript
SA Transcripts · 2026-05-02 · via All Articles on Seeking Alpha

Q1: 2026-05-01 Earnings Summary

EPS of $0.49 beats by $0.04

 | 

Revenue of

$21.98M

(12.65% Y/Y)

beats by $664.00K

IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call May 1, 2026 11:00 AM EDT

Company Participants

Roger Susi - Founder, Chairman, CEO & President
John Glenn - CFO & Corporate Secretary

Conference Call Participants

Frank Takkinen - Lake Street Capital Markets, LLC, Research Division

Presentation

Operator

Welcome to IRadimed Corporation's First Quarter of 2026 Financial Results Conference Call. [Operator Instructions] This call is being recorded today, May 1, 2026, and contains time-sensitive accurate information that is valid only for today. Earlier, IRadimed released its financial results for the first quarter of 2026. A copy of this press release announcing the company's earnings is available under the heading News on their website at iradimed.com. A copy of the press release was also furnished to the Securities and Exchange Commission on Form 8-K and can be found at sec.gov.

This call is being broadcast live on the company's website at iradimed.com, and a replay will be available there for the next 90 days. Some of the information in today's session will constitute forward-looking statements with the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements focus on the future performance, results, plans, and events and may include the company's expected future results. IRadimed reminds you that future results may differ materially from these forward-looking statements due to several risk factors. For a description of the relevant risks and uncertainties that may affect the company's business, please see the Risk Factors section of the company's most recent reports filed with the Securities and Exchange Commission, which may be obtained free from the SEC's website at sec.gov.

I want to turn the call over to Roger Susi, President and Chief Executive Officer of IRadimed Corporation. Mr. Susi?

Roger Susi
Founder, Chairman, CEO & President

Thank you, operator, and good morning. Welcome to IRadimed's Q1